QUADRANT CAPITAL GROUP LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2024$46,642
-6.8%
342
+3.3%
0.00%
-25.0%
Q1 2024$50,038
+24.9%
331
+4.1%
0.00%
+33.3%
Q4 2023$40,053
+156.1%
318
+90.4%
0.00%
+50.0%
Q3 2023$15,638
-10.6%
167
-14.8%
0.00%0.0%
Q2 2023$17,493
-41.5%
196
-29.7%
0.00%
-33.3%
Q1 2023$29,915
-30.0%
279
-20.3%
0.00%
-40.0%
Q4 2022$42,746
+47.4%
350
+25.4%
0.01%
+25.0%
Q3 2022$29,000
+81.2%
279
+59.4%
0.00%
+100.0%
Q2 2022$16,000
-33.3%
175
-14.6%
0.00%
-33.3%
Q1 2022$24,000
-33.3%
205
-22.3%
0.00%
-25.0%
Q4 2021$36,000
+5.9%
264
+23.9%
0.00%
-20.0%
Q3 2021$34,000
+47.8%
213
+23.8%
0.01%
+66.7%
Q2 2021$23,000
+155.6%
172
+145.7%
0.00%
+200.0%
Q1 2021$9,000
+28.6%
70
+59.1%
0.00%0.0%
Q4 2020$7,000
+75.0%
44
+63.0%
0.00%0.0%
Q3 2020$4,0000.0%27
+3.8%
0.00%0.0%
Q2 2020$4,000260.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 4,240,536$300,484,00016.06%
Sofinnova Investments, Inc. 2,479,514$175,698,00015.66%
Vivo Capital, LLC 2,166,832$153,542,00015.48%
VHCP Management II, LLC 504,210$35,728,0009.54%
EcoR1 Capital, LLC 1,087,257$77,043,0006.94%
Avoro Capital Advisors LLC 1,963,336$139,122,0006.39%
Foresite Capital Management IV, LLC 245,424$17,391,0005.70%
Eventide Asset Management 1,544,900$109,472,0004.02%
Orbimed Advisors 4,155,891$294,486,0003.55%
Ghost Tree Capital, LLC 225,000$15,944,0003.39%
View complete list of ASCENDIS PHARMA A/S shareholders